GPx4 inhibits tumor angiogenesis and malignancy through blocking eicosanoid synthesis, including COX-2, prevented TNF-mediated activation of cytokine-driven NF-κB and prostaglandin PGE2 production and abrogated PGE2-dependent COX-2 expression [195]. This evidence concerns the gene TNF and neoplasm.